Riassunto
L'A. dà la definizione della resistenza insulinica cronica e ne riassume le caratteristiche cliniche. Sebbene nella maggior parte dei pazienti con insulino-resistenza cronica possa essere dimostrato l'aumento di anticorpi anti-insulina, non sempre esiste una buona correlazione tra gravità dell'insulino-resistenza e titolo di anticorpi anti-insulina. L'A. descrive diversi casi di pazienti insulino-resistenti che potrebbero rappresentare esempi di insensibilità tissutale periferica all'insulina, ed infine passa in rassegna varie forme di trattamento dell'insulino-resistenza cronica.
Resume
L'A. donne une définition de la résistance insulinique cronique et fait un résumé des caractéristiques cliniques. Dans la majorité des sujets avec insulino-résistance cronique on peut démontrer l'augmentation des anticorps anti-insuliniques, tandis que n'existe pas toujours une bonne corrélation entre la gravité de l'insulino-résistance et le titre des anticorps anti-insuliniques. L'A. décrit plusieures cas de sujets insulino-résistantes qui pourraient représenter des exemples d'insensibilité tissulaire périphérique à l'insuline et discute sur la possibilité de différents traitements de l'insulino-résistance chronique.
Resumen
El A. nos define la resistencia crónica a la insulina y nos resume sus características clínicas. Aunque en la mayor parte de los enfermos insulinorresistentes crónicos se pueda demostrar el aumento de anticuerpos antinsulina, no siempre existe una buena correlación entre la gravedad de la insulinorresistencia y el porcentaje de anticuerpos antinsulina. El A. describe diversos casos de enfermos insulinorresistentes que podrían constituir ejemplos de insensibilidad hística periférica a la insulina y finalmente expone varias formas de tratamiento de la insulinorresistencia crónica.
Zusammenfassung
Der A. liefert die Definition der chronischen Insulin-Resistenz und fasst die klinischen Merkmale zusammen. Obwohl man beim Grossteil der Patienten mit chronischer Insulin-Resistenz die Zunahme der Insulin-Antikoerper nachweisen kann, besteht nicht immer eine gute Korrelation zwischen Schweregrad der Insulin-Resistenz und Insulinantikoerper-Titer. Der A. beschreibt einige Faelle von insulin-resistenten Patienten, die das Beispiel einer peripheren Gewebeunempfindlichkeit gegenueber dem Insulin darstellen koennten und bespricht zuletzt verschiedene Behandlungsformen der chronischen Insulin-Resistenz.
Summary
Chronic insulin resistance has been defined and its clinical characteristics summarized. Although increased insulin antibodies can be demonstrated in most patients with chronic insulin resistance, there is not always a good correlation between the severity of the insulin resistance and the titer of insulin antibodies. Several insulin resistant patients have been described who appear to represent examples of peripheral tissue unresponsiveness to insulin. Various forms of treatment of chronic insulin resistance have been reviewed.
Bibliografia
Akre P. R., Kirtley W. R., Galloway J. A.: Comparative Hypoglycemia Response of Diabetic Subjects to Human Insulin or Structurally Similar Insulins of Animal Source - Diabetes13 135, 1964.
Arquilla E. R., Stavitsky A. B.: The Production and Identification of Antibodies to Insulin and Their Use in Assaying Insulin - J. clin. Invest.35 458, 1956.
Arquilla E. R., Stavitsky A. B.: Evidence for the Insulin-Directed Specificity of Rabbit Anti-Insulin Serum - J. clin. Invest.35 467, 1956.
Axelrod A., Lobe S., Orten J., Myers G.: Insulin Resistance - Ann. intern. Med.27 555, 1947.
Barrett J. C., Boshell B. R.: Tolbutamide in the Therapy of Insulin Resistance - Diabetes11 (suppl.), 35, 1962.
Barrett J. C., Boshell B. R., Carr J. - Diabetes (in press).
Berson S. A., Yalow R. S.: Quantitative Aspects of the Reaction between Insulin and Insulin-Binding Antibody - J. clin. Invest.38 1996, 1959.
Berson S. A., Yalow R. S.: Insulin in Blood and Insulin Antibodies -Amer. J. Med.40 676, 1966.
Berson S. A., Yalow R. S., Bauman A., Rothchild M. A., Newerly K.: Insulin-131I Metabolism in Human Subjects: Demonstration of Insulin Binding Globulin in the Circulation of Insulin Treated Subjects - J. clin. Invest.35 170, 1956.
Boshell B. R., Barrett J. C., Wolinsky A. S., Paten T. B.: Insulin Resistance. Response to Insulin from Various Animal Sources, Including Human - Diabetes13 144, 1964.
Buchanan J., Young E. J.: Insulin Resistance in Haemochromatosis -Postgrad. med. J.42 551, 1966.
Butterfield W. J. H., Thompson R. H. S.: The Effect of Dimercaprol (BAL) on Blood Sugar and Pyruvate Levels in Diabetes Mellitus - Clin. Sci.16 679, 1957.
Colwell A. R., Weiger R. W.: Inhibition of Insulin Action by Serum Gamma Globulin -J. Lab. clin. Med.47 844, 1956.
Davidson J. K. III, Eddleman E. E. Jr.: Insulin Resistance - Arch. intern. Med.86 727, 1950.
Devlin J. G., Braion T., Stephenson N.: Relation between Antibody and Insulin Dose -Brit. med. J.1 542, 1967.
Devlin J. G., Brian T. G.: Relationship between Differential Antibody Binding Capacity and Clinical Requirements of Beef and Pork Insulin - Metabolism14 1034, 1965.
Ezrin C., Moloney P. J.: Resistance to Insulin Due to Neutralizing Antibodies - J. clin. Endocr.19 1055, 1959.
Faludi G., Mehbod H.: Modified Pork Insulin in the Treatment of Insulin Resistant Diabetes- J. Amer. med. Wom. Ass.20 333, 1965.
Feldman R., Grodsky G., Kohout F. W., McWilliams N. B.: Immunologic Studies in a Diabetic Subject Resistant to Bovine Insulin but Sensitive to Porcine Insulin - Amer. J. Med.35 411, 1963.
Field J. B.: Studies on Steroid Treatment of Chronic Insulin Resistance - Diabetes11 165, 1962.
Field J. B.: Insulin Resistance in Diabetes - Ann. Rev. Med.13 249, 1962.
Field J. B., Johnson P., Herring B.: Insulin-Resistant Diabetes Associated with Increased Endogenous Plasma Insulin Followed by Complete Remission - J. clin. Invest.40 1672, 1961.
Field J. B., Woodson M. L.: Studies on the Circulating Insulin Inhibitor Found in Some Diabetic Patients Exhibiting Chronic Insulin Resistance - J. clin. Invest.38 551, 1959.
Friedlander E. O.: Use of Tolbutamide in Insulin-Resistant Diabetes; Report of a Case -New Engl. J. Med.257 11, 1957.
Friedlander E. O.: Use of ACTH and Adrenocortical Steroids in Idiopathic Insulin-Resistant Diabetes - J. Maine med. Ass.51 229, 1960.
Friedlander E. O., Bryant M. D. Jr.: Idiopathic Insulin-Resistant Diabetes Mellitus - Amer. J. Med.26 139, 1959.
Geller W., Ladue J. S., Glass G. B. Jr.: Insulin-Resistant Diabetes Precipitated by Cortisone and Reversed by Nitrogen Mustard - Arch. intern. Med.87 124, 1951.
Glen A., Eaton J. E.: Insulin Antagonism - Quart. J. Med.7 271, 1938.
Goldman A. S., Kaye R.: Insulin Resistance in a Diabetic Child -Diabetes11 122, 1962.
Goldner M. G., Clark D. E.: The Insulin Requirement of Man after Total Pancreatectomy -J. clin. Endocr.4 194, 1944.
Goldschmied A. L., Laurian L.: Sulphated Insulin in Resistant Juvenile Diabetes - Lancet2 405, 1968.
Greenberg W. V.: Insulin Resistance: Mechanisms and Management - J. med. Ass. Ga56 108, 1967.
Grodsky G. M., Forsham P. H.: Comparative Binding of Beef and Human Insulin to Insulin Antibodies Produced in Man and Guinea Pigs - J. clin. Invest.40 799, 1961.
Grodsky G. M., Peng C. T., Forsham P. H.: Effect of Modification of Insulin on Specific Binding in Insulin-Resistant Sera - Arch. Biochem.81 264, 1959.
Guthrie R. A., Murphy D. Y. N., Wolmack W.: Insulin Resistance in Diabetes in Juveniles. A Case Report in a Child and a Review of the Literature - Pediatrics40 642, 1967.
Haunz E. A.: Present Status of Insulin Resistance; Report of a Case with Autopsy - Arch. intern. Med.83 515, 1949.
Himsworth H. P.: Diabetes Mellitus. Its Differentiation into Insulin-Sensitive and Insulin-Insensitive Types - Lancet1 127, 1936.
Joiner C. L.: Rate of Clearance of Insulin Labelled with131I from the Subcutaneous Tissues in Normal and Diabetic Subjects - Lancet1 964, 1959.
Kalant N., Gomberg C., Schucher R.: The Effect of Insulin-Binding Antibodies on Insulin Sensitivity - Lancet2 614, 1958.
Kantor F. S., Berkman P. M.: Steroid Amelioration of Immunogenic Insulin-Resistant Diabetes: A Proposed Mechanism - Yale J. Biol. Med.40 46, 1967.
Karam J. H., Grodsky G. M., Forsham P. H.: Insulin-Resistant Diabetes with Autoantibodies Induced by Exogenous Insulin - Diabetes18 445, 1969.
Kaye M., McGarry E., Rosenfeld I.: Acquired Insulin Resistance. A Case Report - Diabetes4 133, 1955.
Lerman J.: Insulin Resistance. The Role of Immunity in Its Production - Amer. J. med. Sci.207 354, 1944.
Little J. A., Arnott J. H.: Sulfated Insulin in Mild, Moderate, Severe and Insulin-Resistant Diabetes Mellitus - Diabetes15 457, 1966.
Loveless M. H., Cann J. R.: Distribution of Blocking Antibody in Human Serum Proteins Fractionated by Electrophoresis-Convection - J. Immunol.74 329, 1955.
Lowell F. C.: Evidence for the Existence of Two Antibodies for Crystalline Insulin - Proc. Soc. exp. Biol. (N.Y.)50 167, 1942.
Lowell F. C.: Immunologic Studies in Insulin Resistance. II. The Presence of a Neutralizing Factor in the Blood Exhibiting Some Characteristics of an Antibody - J. clin. Invest.23 233, 1944.
Marble A., Bailey C. C.: Hemochromatosis - Amer. J. Med.11 590, 1951.
Martin W. P., Martin H. E., Lyster R. W., Strouse E.: Insulin Resistance - J. clin. Endocr.1 387, 1941.
Menczel J., Levy M., Bentwich Z.: Insulin Resistant Diabetes Treated with Sulfated Insulin -Israel J. med. Sci.2 764, 1966.
Miller B. H.: Idiopathic Insulin Resistance. A Case Report and Review - Virginia med. Mth.93 562, 1966.
Mirsky I. A.: The Role of Insulinase and Insulinase-Inhibitors - Metabolism5 138, 1956.
Mitchell M. L.: Abnormal Insulin-Binding Fraction Demonstrated by the Electrophoresis on Ion-Exchange Paper of Sera from Diabetic Patients - J. clin. Endocr.20 1319, 1960.
Molnar G. D., Striebel J. L., Goetz F. L., McGurkin W. F.: On the Use of Phenformin to Reduce High Insulin Requirements in Diabetes Mellitus - Proc. Mayo Clin.37 455, 1962.
Moore E. W., Mitchell M. L., Chalmers T. C.: Variability in Absorption of Insulin-131I in Normal and Diabetic Subjects after Subcutaneous and Intramuscular Injection - J. clin. Invest.38 1222, 1959.
Morse J. H.: Correlation of Insulin Requirements with the Concentration of Insulin-Binding Antibody in Two Cases of Insulin Resistance - J. clin. Endocr.21 533, 1961.
Oakley W. G., Field J. B., Sowton G. E., Rigby B., Cunliffe A. C.: Action of Prednisone in Insulin-Resistant Diabetes - Brit. med. J.1 1601, 1959.
Oakley W. G., Jones V. E., Cunliffe A. C.: Insulin Resistance - Brit. med. J.2 134, 1967.
Palumbo P. J., Molnar G. D., Tauxe W. N.: Adrenal Steroid Therapy in Insulin Resistance: A Clinical and Immunologic Study - Proc. Mayo Clin.39 161, 1964.
Presland J. R., Todd C. M.: An Investigation of Prolonged Insulin Resistance in a Case of Diabetes Mellitus - Quart. J. Med.25 275, 1956.
Segal B. M.: Insulin Inhibition and Antagonism - Metabolism13 753, 1964.
Shipp J. C., Cunningham R. W., Russel R. O., Marble A.: Insulin Resistance: Clinical Features, Natural Course and Effects of Adrenal Steroid Treatment - Medicine (Baltimore)44 165, 1965.
Shipp J. C., Russel R. O., Steinke J., Mitchell M. L., Hadley W. B.: Insulin Resistance with High Levels of Circulating Insulin-Like Activity Demonstrable in Vitro and in Vivo -Diabetes10 1, 1961.
Skom J. H., Talmadge D. W.: The Role of Nonprecipitating Insulin Antibodies in Diabetes -J. clin. Invest.37 787, 1958.
Smelo L. S.: Insulin Resistance - Proc. Amer. Diabetes Assoc.8 77, 1948.
Somogyi M.: Diabetogenic Effect of Hyperinsulinism - Amer. J. Med.26 192, 1959.
Steinke J., Soeldner J. S.: Insulin Resistance. Differentiation into Two Types by Measurement of Serum Insulin-Like Activity in Vitro - Diabetes14 432, 1965.
Tucker W. R., Klink D., Goetz F. C., Salme E., Knowles H. S. Jr.: Insulin Resistance and Acanthosis nigricans - Diabetes13 395, 1964.
Yalow R. S., Berson S. A.: Immunoassay of Endogenous Plasma Insulin in Man - J. clin. Invest.39 1157, 1960.
Yalow R. S., Berson S. A.: Reaction of Fish Insulins with Human Insulin Antiserums -New Engl. J. Med.270 1171, 1964.
Author information
Authors and Affiliations
Additional information
This work was supported by the United States Public Health Service Grant AM 06865 from the National Institutes of Health.
Rights and permissions
About this article
Cite this article
Field, J.B. Chronic insulin resistance. Acta diabet. lat 7, 220–242 (1970). https://doi.org/10.1007/BF01556784
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01556784